Celldex Therapeutics, Inc

(NASDAQ:CLDX)

Latest On Celldex Therapeutics, Inc (CLDX):

Date/Time Type Description Signal Details
2023-05-18 18:33 ESTNewsCelldex Therapeutics: Revolutionizing Cancer Care With Innovative ImmunotherapiesN/A
2023-05-04 23:29 ESTNewsCelldex GAAP EPS of -$0.62, revenue of $1MN/A
2023-03-02 14:39 ESTNewsCelldex Therapeutics (CLDX) Presents At AAAAI ConferenceN/A
2023-02-28 18:15 ESTNewsCelldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35MN/A
2023-02-27 12:59 ESTNewsCelldex gains 12% on Phase 1 data for urticaria candidateN/A
2023-02-20 07:02 ESTNewsCelldex: Long List Of Failures, High Valuation, But Good Data RecentlyN/A
2022-12-02 20:42 ESTNewsCelldex: Shares Continue To Rally On Barzolvolimab Hope (Technical Analysis)N/A
2022-11-09 22:05 ESTNewsCelldex GAAP EPS of -$0.57 beats by $0.01, revenue of $0.41M beats by $0.05MN/A
2022-08-09 00:09 ESTNewsCelldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24MN/A
2022-07-22 13:36 ESTNewsCelldex begins dosing in mid-stage study of barzolvolimab for skin disorderN/A
2022-07-14 20:11 ESTNewsCelldex: Barzolvolimab Plus Bispecific Antibodies AdvancementN/A
2022-07-01 20:44 ESTNewsCelldex posts early-stage data to support dose-dependent effect of urticaria therapyN/A
2022-05-06 00:47 ESTNewsCelldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39MN/A
2022-03-01 04:31 ESTNewsCelldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84MN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-28 08:33 ESTNewsCelldex Q4 2021 Earnings PreviewN/A
2022-02-17 13:49 ESTNewsCelldex Therapeutics (CLDX) Investor Presentation - SlideshowN/A
2022-02-01 06:48 ESTNewsCelldex: Pipeline Of Drug Candidates Is Worth A LookN/A
2021-11-12 18:41 ESTNewsCelldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody programN/A
2021-11-10 04:54 ESTNewsCelldex EPS misses by $0.09, misses on revenueN/A
2021-09-29 12:19 ESTNewsCelldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patientsN/A
2021-09-24 01:18 ESTNewsCelldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-MakersN/A
2021-08-06 00:09 ESTNewsCelldex EPS beats by $0.06, beats on revenueN/A
2021-07-22 20:52 ESTNewsCelldex rises with bullish call from Guggenheim; potential of lead asset citedN/A
2021-07-21 00:15 ESTNewsCelldex: Powerful Medicines To Yield Further UpsidesN/A
2021-07-21 00:14 ESTNewsCelldex gains over a third on early-stage data for CDX-0159 in skin conditionN/A
2021-07-21 00:13 ESTNewsAnimal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst actionN/A
2021-07-21 00:13 ESTNewsTempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losersN/A
2021-07-21 00:12 ESTNewsCelldex Therapeutics proposes $175M capital raiseN/A
2021-07-21 00:12 ESTNewsCelldex's Latest Data For Chronic Inducible Urticaria Drug Is Only The BeginningN/A
2021-07-21 00:10 ESTNewsCelldex Therapeutics raises $250M via equity offeringN/A
2021-05-07 05:42 ESTNewsCelldex EPS misses by $0.08, misses on revenueN/A
2021-03-30 03:43 ESTNewsCelldex EPS misses by $0.18, beats on revenueN/A
2021-03-29 08:13 ESTNewsCelldex reports 80% complete response rate in CDX-0159 study in skin allergyN/A
2021-03-02 07:24 ESTAnalyst RatingThe Analyst Target Price has increased from $30.67 to $34.33.Buy
2021-02-24 03:23 ESTAnalyst RatingThe Analyst Target Price has increased from $26.33 to $30.67.Buy
2021-02-22 18:38 ESTNewsCelldex to expand development of CDX-0159 into prurigo nodularisN/A
2021-01-17 17:51 ESTNewsCelldex: New Monoclonal Therapeutic Line, 1Q21's CDX-0159's Initial Trial Data, And MoreN/A
2020-12-13 03:34 ESTFinancialsCompany financials have been released.Neutral
2020-12-09 15:50 ESTNewsDosing underway in Celldex's CDX-0159 study in skin allergyN/A
2020-11-19 19:29 ESTAnalyst RatingThe Analyst Target Price has increased from $23.5 to $26.33.Buy
2020-11-10 03:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:34 ESTAnalyst RatingThe Analyst Target Price has increased from $21.5 to $23.5.Buy
2020-11-07 15:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 19:23 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 04:46 ESTNewsCelldex EPS in-line, beats on revenueN/A
2020-11-01 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $17 to $21.5.Buy
2020-10-14 09:13 ESTNewsDosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder studyN/A

About Celldex Therapeutics, Inc (CLDX):

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

CLDX Quotes by TradingView

See Advanced Chart

General

  • Name Celldex Therapeutics, Inc
  • Symbol CLDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 127
  • Last Split Factor1:15
  • Last Split Date2019-02-11
  • Fiscal Year EndDecember
  • IPO Date2008-03-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.celldex.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 133.88
  • Price/Book (Most Recent Quarter) 4.37
  • Enterprise Value Revenue 186.73
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -1150%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 4.52 million
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.19
  • Gross Profit -39099000
  • Quarterly Earnings Growth 22.3%
View More

Highlights

  • Market Capitalization 988.78 million
  • EBITDA -51311000
  • PE Ratio -18.24
  • Analyst Target Price $34.33
  • Book Value Per Share $5.81
View More

Share Statistics

  • Shares Outstanding 39.57 million
  • Shares Float 28.85 million
  • % Held by Insiders 16%
  • % Held by Institutions 82.07%
  • Shares Short 2.87 million
  • Shares Short Prior Month 3.44 million
  • Short Ratio 4.18
  • Short % of Float 7%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.73
  • 52 Week High $30.17
  • 52 Week Low $1.51
  • 50 Day Moving Average 25.2
  • 200 Day Moving Average 18.9
View More

Dividends

  • Dividend Date 2019-02-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Celldex Therapeutics, Inc (CLDX) Dividend Calendar:

CLDX's last dividend payment was made to shareholders on February 11, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Celldex Therapeutics, Inc (CLDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$668000-$0.36-$0.360%
2020-06-302020-08-06$N/A-$0.50-$0.5813.79%
2020-03-312020-05-06$2.73 million-$0.73-$0.70-4.29%
2019-12-312020-03-26$887000-$0.64-$0.9331.18%
2019-09-302019-11-12$546000-$0.75-$0.8410.71%
2019-06-302019-08-07$715000-$0.84-$1.1728.21%
2019-03-312019-05-07$1.43 million-$1.40-$1.14-22.81%
2018-12-312019-03-07$1.76 million-$0.81-$1.2032.5%
2018-09-302018-11-07$941000-$0.60-$2.2573.33%
2018-06-302018-08-08$2.76 million-$1.65-$2.5535.29%
2018-03-312018-05-10$4.07 million-$12.60-$3.03-315.84%
2017-12-312018-03-07$3.46 million-$0.45-$3.7387.92%
2017-09-302017-11-07$3.92 million-$3.00-$3.9824.53%
2017-06-302017-08-08$3.83 million-$3.45-$4.0915.71%
2017-03-312017-05-09$1.53 million-$4.20-$4.281.75%
2016-12-312017-03-14$1.87 million-$4.50-$5.0510.89%
2016-09-302016-11-07$2.22 million-$4.35-$4.9712.42%
2016-06-302016-08-08$1.39 million-$4.80-$5.054.95%
2016-03-312016-05-05$1.3 million-$5.25-$5.24-0.29%
2015-12-312016-02-23$1.79 million-$4.95-$5.204.81%
2015-09-302015-11-05$1.03 million-$0.32-$0.358.57%
2015-06-302015-08-10$2.18 million-$0.33-$0.342.94%
2015-03-312015-04-29$486000-$0.33-$0.368.33%
2014-12-312015-02-24$1.48 million-$0.36-$0.35-2.86%
2014-09-302014-11-05$1.1 million-$0.31-$0.336.06%
2014-06-302014-08-06$592000-$4.80-$4.840.83%
2014-03-312014-05-01$416000-$4.95-$3.94-25.63%
2013-12-312014-03-03$620000-$4.05-$4.183.11%
2013-09-302013-11-08$980000-$4.35-$3.66-18.85%
2013-06-302013-08-06$97000-$3.60-$3.34-7.78%
2013-03-312013-05-02$2.41 million-$3.45-$3.30-4.55%
2012-12-312013-03-07$3.65 million-$4.05-$3.75-8%
2012-09-302012-11-01$3.11 million-$3.75-$3.62-3.59%
2012-06-302012-08-10$2.01 million-$3.45-$3.798.97%
2012-03-312012-05-03$2.43 million-$4.05-$3.57-13.45%
2011-12-312012-03-07$2.43 million-$4.35-$4.17-4.32%
2011-09-302011-11-02$2.36 million-$4.05-$3.84-5.47%
2011-06-302011-08-03$1.95 million-$4.05-$4.295.59%
2011-03-312011-05-04$2.52 million-$4.65-$4.54-2.42%
2010-12-312011-03-03$2.13 million-$3.60$3.15-214.29%
2010-09-302010-11-02$2.41 million-$4.35-$4.8710.68%
2010-06-302010-08-04$2.95 million-$4.50-$3.95-13.92%
2010-03-312010-05-04$3.71 million-$3.15-$3.9520.25%
2009-12-312010-03-04$4.73 million-$6.45-$4.30-50%
2009-09-302009-11-04$4.03 million-$6.75-$8.3218.87%
2009-06-302009-08-05$2.69 million-$8.25-$7.10-16.2%
2009-03-312009-05-05$3.73 million-$7.35-$6.90-6.52%
2008-12-312009-02-27$2.99 million-$7.05-$8.1012.96%
2008-09-302008-11-05$2.36 million-$7.50-$7.20-4.17%
2008-06-302008-08-06$1.96 million-$10.05-$8.40-19.64%
2008-03-312008-05-19$147000-$32.85-$9.97-229.49%
2007-12-312008-02-27$384000-$26.19
2007-09-302007-10-31$269000-$12.60-$12.600%
2007-06-302007-08-02$609000-$12.60-$18.0030%
2007-03-312007-05-03$144000-$87.35
2006-12-312007-03-07$255000-$14.40-$14.400%
2006-09-302006-11-01$199000-$14.40-$12.60-14.29%
2006-06-302006-08-02$317000-$14.40-$12.60-14.29%
2006-03-312006-05-09$128000-$7.20-$5.40-33.33%
2005-12-312006-03-08$36000-$9.00-$10.8016.67%
2005-09-302005-10-27$23000-$10.80-$12.6014.29%
2005-06-302005-08-03$12000-$10.80-$6.30-71.43%
2005-03-312005-05-05$N/A-$12.60-$11.70-7.69%
2004-12-312005-03-02-$9.00-$10.8016.67%
2004-09-302004-10-20-$8.98
2004-06-302004-07-22-$9.00-$9.000%
2004-03-312004-04-21-$5.40-$9.0040%
2003-12-312004-02-24-$9.00-$9.000%
2003-09-302003-10-22-$5.40-$10.8050%
2003-06-302003-07-23-$9.48
2003-03-312003-04-30-$10.01
2002-12-312003-02-26-$10.80-$12.6014.29%
2002-09-302002-10-23-$1.80-$16.2088.89%
2002-06-302002-07-24-$16.20-$17.105.26%
2002-03-312002-04-24-$14.40-$18.0020%
2001-12-312002-02-26-$19.80-$20.402.94%
2001-09-302001-10-25-$19.80-$23.4015.38%
2001-06-302001-08-02-$18.00-$22.8021.05%
2001-03-312001-04-25-$12.60-$16.2022.22%
2000-12-312001-03-01-$14.40-$13.50-6.67%
2000-09-302000-10-25-$12.60-$12.600%
2000-06-302000-06-30-$9.79
2000-03-312000-04-27-$7.20-$10.8033.33%
1996-12-311997-02-19-$16.20-$18.0010%
1996-09-301996-11-06-$18.00-$18.000%
1996-06-301996-07-23-$39.60-$18.00-120%
1995-12-311996-02-27-$28.80-$25.20-14.29%
1995-09-301995-11-10-$32.40-$27.00-20%
1995-06-301995-08-11-$27.00-$25.20-7.14%
1995-03-311995-05-12-$25.20-$23.40-7.69%
1994-12-311995-02-15-$19.80-$35.1043.59%
1994-09-301994-11-10-$23.40-$24.303.7%
1994-06-301994-08-02-$23.40-$25.207.14%
1994-03-311994-05-02-$19.80-$25.2021.43%
1993-09-301993-10-29-$27.00-$21.60-25%
1993-03-311993-05-12-$23.40-$18.00-30%

Celldex Therapeutics, Inc (CLDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 10.71 million N/A 11.7 million N/A 11.1 million
Income Before Tax -14.22 million N/A -12.63 million -10.45 million -11.41 million
Selling General Administrative 4.3 million N/A 3.67 million 3.22 million 3.4 million
Gross Profit 668000 N/A N/A -9.45 million 546000
Ebit -14.22 million N/A -11.47 million -12.67 million -13.96 million
Operating Income -14.34 million N/A -12.63 million -12.67 million -13.96 million
Income Tax Expense N/A -228000 N/A N/A N/A
Total Revenue 668000 N/A 2.73 million 887000 546000
Cost of Revenue N/A N/A N/A 10.34 million N/A
Total Other Income Expense Net N/A N/A 8000 2.22 million 2.55 million
Net Income From Continuing Operations -14.22 million N/A -12.63 million -10.45 million -11.41 million
Net Income Applicable to Common Shares -14.22 million -11.03 million -12.63 million -10.45 million -11.41 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -42.36 million N/A 21.97 million 3.33 million 5.64 million
Change to Liabilities 1.04 million 599000 N/A 563000 714000
Total Cash Flow from Investing Activities -42.51 million -108.53 million N/A 3.22 million 5.52 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 4.49 million N/A 1.64 million 2.42 million 2.46 million
Change to Operating Activities N/A -1.29 million N/A -2.95 million -357000
Change in Cash -49.88 million N/A 11.49 million -5.35 million -3.16 million
Total Cash from Operating Activities -11.86 million -11.22 million -12.11 million -11 million -11.14 million
Depreciation 774000 N/A 1.17 million 1.15 million 1.21 million
Other Cash Flow from Investing Activities 9000 N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A -161000 443000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 1.9 million -1.43 million N/A 849000 -1.74 million
Capital Expenditures 160000 N/A 235000 105000 142000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 25.8 million N/A 28.8 million 28.91 million 30.46 million
Total Stockholder Equity 229.98 million N/A 83.7 million 94.03 million 101.38 million
Other Current Liabilities 3.63 million N/A 1.99 million 2.03 million 2.55 million
Total Assets 255.77 million N/A 112.5 million 122.93 million 131.84 million
Common Stock 40000 39000 83.7 million 17000 16000
Other Current Assets 2.49 million N/A N/A N/A N/A
Retained Earnings -1.05 billion -1.04 billion -1.03 billion -1.01 billion -1 billion
Other Liabilities N/A 10.4 million 17.87 million 15.55 million 17.09 million
Other Assets N/A 41000 N/A 41000 129000
Cash 18.15 million N/A 22.72 million 11.23 million 16.59 million
Total Current Liabilities 12.2 million N/A 10.93 million 11.64 million 11.89 million
Other Stockholder Equity 2.61 million 2.59 million N/A 2.62 million 2.64 million
Property, Plant & Equipment 3.81 million 7.18 million 4.12 million 7.5 million 7.92 million
Total Current Assets 202.93 million N/A 55.92 million 66.7 million 75.1 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 184.79 million 193.25 million 31.23 million 45.34 million 52.69 million
Short Term Investments 181.44 million N/A 31 million 53.15 million 56.33 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 8.58 million N/A 1.61 million 1.17 million 666000

Celldex Therapeutics, Inc (CLDX) Chart:

Celldex Therapeutics, Inc (CLDX) News:

Below you will find a list of latest news for Celldex Therapeutics, Inc (CLDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Celldex Therapeutics, Inc (CLDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-20150CALL0 00TRUE00
2026-03-20160CALL0 00TRUE00
2026-03-20170CALL0 00TRUE00
2026-03-20180CALL0 00TRUE00
2026-03-20190CALL0 00TRUE00
2026-03-20207.15CALL0 100TRUE00
2026-03-20210CALL0 00TRUE00
2026-03-20220CALL0 00TRUE00
2026-03-20230CALL0 00TRUE00
2026-03-20241.9CALL0 2880TRUE00
2026-03-20252.6CALL0 50TRUE00
2026-03-20261CALL0 568.43TRUE00
2026-03-20272.9CALL0 12856.59TRUE00
2026-03-20283.7CALL0 567.72TRUE00
2026-03-20291CALL0 167.45TRUE00
2026-03-20301.47CALL0 18137.59TRUE00
2026-03-20310.05CALL0 1124.98TRUE00
2026-03-20320.53CALL0 13251.29FALSE00
2026-03-20330.45CALL0 1267.53FALSE00
2026-03-20340.6CALL0 3132.38FALSE00
2026-03-20350.51CALL0 5302.67FALSE00
2026-03-20360CALL0 0317.5FALSE00
2026-03-20370CALL0 0331.46FALSE00
2026-03-20380CALL0 0344.64FALSE00
2026-03-20390.43CALL0 2357.15FALSE00
2026-03-20400CALL0 0369.04FALSE00
2026-03-20410CALL0 0380.39FALSE00
2026-03-20420CALL0 0221.9FALSE00
2026-03-20430CALL0 0308.52FALSE00
2026-03-20440CALL0 0411.62FALSE00
2026-03-20450CALL0 0121.33FALSE00
2026-03-20150.2PUT0 4815.25FALSE00
2026-03-20160PUT0 0761.5FALSE00
2026-03-20170PUT0 0712.2FALSE00
2026-03-20180.25PUT0 1666.61FALSE00
2026-03-20190.55PUT0 1624.15FALSE00
2026-03-20200.42PUT0 37251.45FALSE00
2026-03-20210PUT0 0546.81FALSE00
2026-03-20221.05PUT0 4511.21FALSE00
2026-03-20231.9PUT0 1302.9FALSE00
2026-03-20241.4PUT0 1444.77FALSE00
2026-03-20250PUT0 0413.47FALSE00
2026-03-20260.6PUT0 2383.17FALSE00
2026-03-20270.65PUT0 2353.7FALSE00
2026-03-20285.24PUT0 20324.85FALSE00
2026-03-20291.32PUT0 1296.43FALSE00
2026-03-20302.05PUT0 3268.21FALSE00
2026-03-20310PUT0 0239.89FALSE00
2026-03-20320PUT0 0211.09TRUE00
2026-03-20330PUT0 069.09TRUE00
2026-03-20340PUT0 079.41TRUE00
2026-03-20350PUT0 074.29TRUE00
2026-03-20360PUT0 074.88TRUE00
2026-03-20370PUT0 062.66TRUE00
2026-03-20380PUT0 070.23TRUE00
2026-03-20390PUT0 099.31TRUE00
2026-03-20400PUT0 0107.36TRUE00
2026-03-20410PUT0 0115.06TRUE00
2026-03-20420PUT0 0122.45TRUE00
2026-03-20430PUT0 0129.56TRUE00
2026-03-20440PUT0 0136.41TRUE00
2026-03-20450PUT0 0143.03TRUE00
2026-04-17150CALL0 00TRUE00
2026-04-17160CALL0 00TRUE00
2026-04-17170CALL0 00TRUE00
2026-04-17180CALL0 00TRUE00
2026-04-17190CALL0 069.9TRUE00
2026-04-17200CALL0 062.02TRUE00
2026-04-17210CALL0 054.48TRUE00
2026-04-17220CALL0 047.24TRUE00
2026-04-17230CALL0 067.72TRUE00
2026-04-17240CALL0 056.03TRUE00
2026-04-17250CALL0 048.77TRUE00
2026-04-17260CALL0 062.14TRUE00
2026-04-17270CALL0 063.46TRUE00
2026-04-17284CALL0 1359.52TRUE00
2026-04-17293.45CALL0 3563.66TRUE00
2026-04-17302.5CALL0 139.09TRUE00
2026-04-17310CALL0 059.26TRUE00
2026-04-17321CALL0 1154.15FALSE00
2026-04-17331CALL0 2137.52FALSE00
2026-04-17340CALL0 076.12FALSE00
2026-04-17350CALL0 0154.47FALSE00
2026-04-17360CALL0 0162.1FALSE00
2026-04-17370CALL0 0169.28FALSE00
2026-04-17380CALL0 0122.84FALSE00
2026-04-17390CALL0 084.06FALSE00
2026-04-17400.5CALL50 067.76FALSE0.50
2026-04-17410CALL0 082.1FALSE00
2026-04-17420CALL0 0200.04FALSE00
2026-04-17430CALL0 0205.38FALSE00
2026-04-17440CALL0 0163.92FALSE00
2026-04-17450CALL0 0215.45FALSE00
2026-04-17150PUT0 0419.32FALSE00
2026-04-17160PUT0 0391.72FALSE00
2026-04-17170PUT0 0366.41FALSE00
2026-04-17180PUT0 0343FALSE00
2026-04-17190PUT0 0321.21FALSE00
2026-04-17200PUT0 0300.78FALSE00
2026-04-17210PUT0 0281.52FALSE00
2026-04-17220PUT0 0263.25FALSE00
2026-04-17230PUT0 0245.84FALSE00
2026-04-17240PUT0 0229.17FALSE00
2026-04-17250PUT0 0213.11FALSE00
2026-04-17260PUT0 0197.58FALSE00
2026-04-17270PUT0 0182.47FALSE00
2026-04-17280PUT0 0167.69FALSE00
2026-04-17290PUT0 090.54FALSE00
2026-04-17300PUT0 0117.78FALSE00
2026-04-17310PUT0 065.24FALSE00
2026-04-17320PUT0 063.86TRUE00
2026-04-17330PUT0 062.23TRUE00
2026-04-17340PUT0 063.64TRUE00
2026-04-17350PUT0 063.78TRUE00
2026-04-17360PUT0 062.58TRUE00
2026-04-17370PUT0 058.9TRUE00
2026-04-17380PUT0 056.62TRUE00
2026-04-17390PUT0 059.24TRUE00
2026-04-17400PUT0 058.68TRUE00
2026-04-17410PUT0 059.77TRUE00
2026-04-17420PUT0 066.83TRUE00
2026-04-17430PUT0 073.61TRUE00
2026-04-17440PUT0 077.4TRUE00
2026-04-17450PUT0 081.06TRUE00
2026-05-151510.4CALL0 10TRUE00
2026-05-15160CALL0 00TRUE00
2026-05-15170CALL0 00TRUE00
2026-05-15180CALL0 00TRUE00
2026-05-15190CALL0 00TRUE00
2026-05-15208.72CALL0 2666.41TRUE00
2026-05-15210CALL0 059.8TRUE00
2026-05-15220CALL0 060.18TRUE00
2026-05-15238.5CALL0 063.43TRUE00
2026-05-15240CALL0 062.33TRUE00
2026-05-15256.95CALL0 17564.84TRUE00
2026-05-15260CALL0 060.13TRUE00
2026-05-15275.49CALL0 562.49TRUE00
2026-05-15284.4CALL0 1662.76TRUE00
2026-05-15293.84CALL0 166.59TRUE00
2026-05-15303.08CALL0 273.53TRUE00
2026-05-15313.5CALL0 362.85TRUE00
2026-05-15322.5CALL0 3361.67FALSE00
2026-05-15331.1CALL0 361.04FALSE00
2026-05-15341.05CALL0 2110.38FALSE00
2026-05-15351.47CALL0 2262.64FALSE00
2026-05-15361.9CALL0 6122.42FALSE00
2026-05-15371.1CALL0 4127.89FALSE00
2026-05-15380CALL0 0133.05FALSE00
2026-05-15391.15CALL0 1137.95FALSE00
2026-05-15400.75CALL0 40142.6FALSE00
2026-05-15411.05CALL0 1147.04FALSE00
2026-05-15421CALL0 1151.28FALSE00
2026-05-15430.5CALL0 2155.35FALSE00
2026-05-15440.45CALL0 1159.25FALSE00
2026-05-15450.45CALL0 9163FALSE00
2026-05-15150.5PUT0 26206.36FALSE00
2026-05-15160.6PUT0 17298.04FALSE00
2026-05-15170.6PUT0 30278.82FALSE00
2026-05-15180.65PUT0 18261.05FALSE00
2026-05-15191.3PUT0 10244.5FALSE00
2026-05-15201.15PUT0 7228.99FALSE00
2026-05-15211.7PUT0 6214.37FALSE00
2026-05-15220PUT0 0200.5FALSE00
2026-05-15232.8PUT0 10127.24FALSE00
2026-05-15242.35PUT0 23174.64FALSE00
2026-05-15251.75PUT0 12162.46FALSE00
2026-05-15263.9PUT0 1150.68FALSE00
2026-05-15270PUT0 0139.22FALSE00
2026-05-15280PUT0 078.64FALSE00
2026-05-15293.6PUT0 269.38FALSE00
2026-05-15305.83PUT0 1064.43FALSE00
2026-05-15310PUT0 065.14FALSE00
2026-05-15320PUT0 068.25TRUE00
2026-05-15330PUT0 063.89TRUE00
2026-05-15340PUT0 064.43TRUE00
2026-05-15357.21PUT0 160.24TRUE00
2026-05-15360PUT0 059.61TRUE00
2026-05-15370PUT0 058.11TRUE00
2026-05-15380PUT0 062.7TRUE00
2026-05-15390PUT0 063.48TRUE00
2026-05-15400PUT0 063.71TRUE00
2026-05-15410PUT0 067.48TRUE00
2026-05-15420PUT0 066.85TRUE00
2026-05-15430PUT0 063.89TRUE00
2026-05-15440PUT0 067TRUE00
2026-05-15450PUT0 066.2TRUE00
2026-08-21150CALL0 064.34TRUE00
2026-08-21160CALL0 070.32TRUE00
2026-08-21170CALL0 072.67TRUE00
2026-08-21180CALL0 066.58TRUE00
2026-08-21190CALL0 070.22TRUE00
2026-08-21200CALL0 069.56TRUE00
2026-08-21210CALL0 070.57TRUE00
2026-08-21220CALL0 068.73TRUE00
2026-08-21239.85CALL0 20070.27TRUE00
2026-08-21249.2CALL0 3868.47TRUE00
2026-08-21253.61CALL0 3664.79TRUE00
2026-08-21260CALL0 068.55TRUE00
2026-08-21273CALL0 069.31TRUE00
2026-08-21282.77CALL0 168.9TRUE00
2026-08-21290CALL0 066.81TRUE00
2026-08-21303.7CALL0 165.11TRUE00
2026-08-21315.7CALL0 264.99TRUE00
2026-08-21322.9CALL0 168.19FALSE00
2026-08-21332.5CALL0 166.46FALSE00
2026-08-21342.15CALL0 165.95FALSE00
2026-08-21352CALL0 368.75FALSE00
2026-08-21363.58CALL0 566.48FALSE00
2026-08-21370CALL0 066.35FALSE00
2026-08-21380CALL0 066.28FALSE00
2026-08-21390CALL0 061.92FALSE00
2026-08-21403.29CALL0 260.97FALSE00
2026-08-21410CALL0 063.99FALSE00
2026-08-21420CALL0 066.24FALSE00
2026-08-21430CALL0 068.37FALSE00
2026-08-21440CALL0 099.98FALSE00
2026-08-21450CALL0 072.99FALSE00
2026-08-21151.6PUT0 9199.05FALSE00
2026-08-21160.75PUT0 3190.8FALSE00
2026-08-21170.8PUT0 3178.57FALSE00
2026-08-21180.9PUT0 10167.27FALSE00
2026-08-21191.8PUT0 2156.75FALSE00
2026-08-21201.95PUT0 1146.89FALSE00
2026-08-21210PUT0 0137.6FALSE00
2026-08-21223PUT0 5088.17FALSE00
2026-08-21230PUT0 082.01FALSE00
2026-08-21242.75PUT0 175.22FALSE00
2026-08-21250PUT0 0104.67FALSE00
2026-08-21260PUT0 070.49FALSE00
2026-08-21270PUT0 071.33FALSE00
2026-08-21280PUT0 071.68FALSE00
2026-08-21290PUT0 071.62FALSE00
2026-08-21300PUT0 068.34FALSE00
2026-08-21310PUT0 070.77FALSE00
2026-08-21320PUT0 069.72TRUE00
2026-08-21330PUT0 067.17TRUE00
2026-08-21340PUT0 066.77TRUE00
2026-08-21350PUT0 066.67TRUE00
2026-08-21360PUT0 064.48TRUE00
2026-08-21370PUT0 065.03TRUE00
2026-08-21380PUT0 068.41TRUE00
2026-08-21390PUT0 066.01TRUE00
2026-08-21400PUT0 066.48TRUE00
2026-08-21410PUT0 067.4TRUE00
2026-08-21420PUT0 068.14TRUE00
2026-08-21430PUT0 066.65TRUE00
2026-08-21440PUT0 066.29TRUE00
2026-08-21450PUT0 065.72TRUE00
2026-10-16150CALL0 082.25TRUE00
2026-10-16200CALL0 077.33TRUE00
2026-10-16210CALL0 077.38TRUE00
2026-10-16220CALL0 076.18TRUE00
2026-10-16230CALL0 076.2TRUE00
2026-10-16240CALL0 076.53TRUE00
2026-10-16250CALL0 075.8TRUE00
2026-10-16260CALL0 076.71TRUE00
2026-10-16270CALL0 075.41TRUE00
2026-10-16280CALL0 076.27TRUE00
2026-10-16290CALL0 076.23TRUE00
2026-10-16300CALL0 075.39TRUE00
2026-10-16317.4CALL0 182.6TRUE00
2026-10-16320CALL0 073.64FALSE00
2026-10-16330CALL0 074.34FALSE00
2026-10-16340CALL0 074.82FALSE00
2026-10-16350CALL0 073.53FALSE00
2026-10-16360CALL0 072.6FALSE00
2026-10-16370CALL0 075.65FALSE00
2026-10-16380CALL0 074.12FALSE00
2026-10-16390CALL0 074.25FALSE00
2026-10-16405CALL0 271.36FALSE00
2026-10-16410CALL0 073.29FALSE00
2026-10-16420CALL0 073.78FALSE00
2026-10-16430CALL0 072.55FALSE00
2026-10-16440CALL0 070.9FALSE00
2026-10-16450CALL0 073.74FALSE00
2026-10-16150PUT0 0177.11FALSE00
2026-10-16200PUT0 088.84FALSE00
2026-10-16210PUT0 082.65FALSE00
2026-10-16220PUT0 076.73FALSE00
2026-10-16230PUT0 078.46FALSE00
2026-10-16240PUT0 080.98FALSE00
2026-10-16250PUT0 079.29FALSE00
2026-10-16260PUT0 077.73FALSE00
2026-10-16270PUT0 077.82FALSE00
2026-10-16280PUT0 077.61FALSE00
2026-10-16290PUT0 076.58FALSE00
2026-10-16300PUT0 075.89FALSE00
2026-10-16310PUT0 074.45FALSE00
2026-10-16320PUT0 073.91TRUE00
2026-10-16330PUT0 074.75TRUE00
2026-10-16340PUT0 074.31TRUE00
2026-10-16350PUT0 075.26TRUE00
2026-10-16360PUT0 072.88TRUE00
2026-10-16370PUT0 072.94TRUE00
2026-10-16380PUT0 073.34TRUE00
2026-10-16390PUT0 073.58TRUE00
2026-10-16400PUT0 073.67TRUE00
2026-10-16410PUT0 074.14TRUE00
2026-10-16420PUT0 073.4TRUE00
2026-10-16430PUT0 073.6TRUE00
2026-10-16440PUT0 073.67TRUE00
2026-10-16450PUT0 072.48TRUE00
2026-11-20150CALL0 0112.02TRUE00
2026-11-20200CALL0 0111.73TRUE00
2026-11-20210CALL0 0111.6TRUE00
2026-11-20220CALL0 0111.2TRUE00
2026-11-20230CALL0 0110.57TRUE00
2026-11-20240CALL0 0109.11TRUE00
2026-11-202511.25CALL0 2107.53TRUE00
2026-11-20260CALL0 0110.09TRUE00
2026-11-20270CALL0 0108.18TRUE00
2026-11-20280CALL0 0110.23TRUE00
2026-11-20290CALL0 0108.64TRUE00
2026-11-20300CALL0 0106.97TRUE00
2026-11-20310CALL0 0107.92TRUE00
2026-11-20320CALL0 0108.7FALSE00
2026-11-20330CALL0 0106.71FALSE00
2026-11-20340CALL0 0107.76FALSE00
2026-11-20350CALL0 0107.64FALSE00
2026-11-20360CALL0 0105.4FALSE00
2026-11-20378.3CALL3 097.16FALSE8.30
2026-11-20380CALL0 0105.7FALSE00
2026-11-20397.7CALL2 296.4FALSE7.70
2026-11-20400CALL0 0105.62FALSE00
2026-11-20410CALL0 0107.9FALSE00
2026-11-20420CALL0 0105.21FALSE00
2026-11-20430CALL0 0107.31FALSE00
2026-11-20440CALL0 0104.5FALSE00
2026-11-20450CALL0 0106.45FALSE00
2026-11-20150PUT0 0117.14FALSE00
2026-11-20200PUT0 0114.01FALSE00
2026-11-20210PUT0 0114.08FALSE00
2026-11-20220PUT0 0114.21FALSE00
2026-11-20230PUT0 0112.4FALSE00
2026-11-20240PUT0 0111.79FALSE00
2026-11-20250PUT0 0111FALSE00
2026-11-20260PUT0 0110.06FALSE00
2026-11-20270PUT0 0108.98FALSE00
2026-11-20280PUT0 0107.78FALSE00
2026-11-20290PUT0 0109.27FALSE00
2026-11-20300PUT0 0109.99FALSE00
2026-11-20310PUT0 0108.93FALSE00
2026-11-20320PUT0 0107.23TRUE00
2026-11-20330PUT0 0108.07TRUE00
2026-11-20340PUT0 0108.76TRUE00
2026-11-20350PUT0 0106.77TRUE00
2026-11-20360PUT0 0101.7TRUE00
2026-11-20370PUT0 0100.11TRUE00
2026-11-20380PUT0 0105.35TRUE00
2026-11-20390PUT0 0106TRUE00
2026-11-20400PUT0 0106.07TRUE00
2026-11-20410PUT0 0106.55TRUE00
2026-11-20420PUT0 0105.96TRUE00
2026-11-20430PUT0 0106.26TRUE00
2026-11-20440PUT0 0105.52TRUE00
2026-11-20450PUT0 0105.67TRUE00
2026-12-181318.92CALL0 34117.14TRUE00
2026-12-18150CALL0 0119.98TRUE00
2026-12-18180CALL0 0117.96TRUE00
2026-12-182014CALL0 1117.37TRUE00
2026-12-182214.37CALL0 15115.88TRUE00
2026-12-182511.4CALL0 1113.1TRUE00
2026-12-18276.03CALL0 0115.42TRUE00
2026-12-18306.5CALL0 10113.41TRUE00
2026-12-183210CALL0 3113.65FALSE00
2026-12-183510.55CALL0 132113.21FALSE00
2026-12-18370CALL0 0112.46FALSE00
2026-12-18408.7CALL0 12110.8FALSE00
2026-12-18420CALL0 0110.29FALSE00
2026-12-18456CALL0 53110.92FALSE00
2026-12-18130PUT0 0129.98FALSE00
2026-12-18150PUT0 0122.92FALSE00
2026-12-18180PUT0 0116.71FALSE00
2026-12-18200PUT0 0116.94FALSE00
2026-12-18220PUT0 0116.1FALSE00
2026-12-18250PUT0 0115.94FALSE00
2026-12-18278.4PUT1 1141109.48FALSE8.40
2026-12-18300PUT0 0114.39FALSE00
2026-12-18320PUT0 0113.48TRUE00
2026-12-183514.35PUT0 1113.12TRUE00
2026-12-18370PUT0 0110.81TRUE00
2026-12-184016.1PUT0 10111.12TRUE00
2026-12-184218.9PUT0 9110.94TRUE00
2026-12-184520.94PUT0 2110.17TRUE00
2027-01-15130CALL0 0116.92TRUE00
2027-01-15150CALL0 0114.95TRUE00
2027-01-15180CALL0 0112.13TRUE00
2027-01-15200CALL0 0111.6TRUE00
2027-01-152311.64CALL0 6112.35TRUE00
2027-01-152514.35CALL0 14110.47TRUE00
2027-01-15270CALL0 0112.55TRUE00
2027-01-15300CALL0 0109.96TRUE00
2027-01-15320CALL0 0109.14FALSE00
2027-01-15350CALL0 0107.74FALSE00
2027-01-15370CALL0 0107.5FALSE00
2027-01-15400CALL0 0109.53FALSE00
2027-01-15420CALL0 0109.01FALSE00
2027-01-15457.4CALL0 3107.8FALSE00
2027-01-15130PUT0 0177.28FALSE00
2027-01-15150PUT0 0117.55FALSE00
2027-01-15180PUT0 0111.64FALSE00
2027-01-15200PUT0 0111.88FALSE00
2027-01-15230PUT0 0116.01FALSE00
2027-01-15250PUT0 0113.88FALSE00
2027-01-15270PUT0 0111.37FALSE00
2027-01-15300PUT0 0112.14FALSE00
2027-01-15320PUT0 0108.71TRUE00
2027-01-153510.11PUT0 6107.94TRUE00
2027-01-153711.39PUT0 1108.54TRUE00
2027-01-15400PUT0 0107.01TRUE00
2027-01-15420PUT0 0106.86TRUE00
2027-01-15450PUT0 0107.92TRUE00

Latest CLDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$20.54
Jun 13, 2022 7:59 PM EST61$20.52
Jun 13, 2022 7:59 PM EST28$20.52
Jun 13, 2022 7:59 PM EST1$20.51
Jun 13, 2022 7:59 PM EST190$20.54

Celldex Therapeutics, Inc (CLDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000003877718000054/0000038777-18-000054-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000021545718005851/0000215457-18-005851-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001108/0000315066-18-001108-index.htm
2018-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001910/0000315066-18-001910-index.htm
2020-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000090266420002780/0000902664-20-002780-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247118003136/0000932471-18-003136-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247119004430/0000932471-19-004430-index.htm
2020-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093583620000571/0000935836-20-000571-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000103738920000083/0001037389-20-000083-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746918001363/0001047469-18-001363-index.htm
2018-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918002964/0001047469-18-002964-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918003326/0001047469-18-003326-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746919000992/0001047469-19-000992-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746919002607/0001047469-19-002607-index.htm
2019-12-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/0001047469-19-006714-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746920001809/0001047469-20-001809-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746920002644/0001047469-20-002644-index.htm
2020-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003564/0001047469-20-003564-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003601/0001047469-20-003601-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003602/0001047469-20-003602-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003646/0001047469-20-003646-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918026170/0001104659-18-026170-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918031972/0001104659-18-031972-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918037447/0001104659-18-037447-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918040165/0001104659-18-040165-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918050496/0001104659-18-050496-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918066648/0001104659-18-066648-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918070024/0001104659-18-070024-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918072097/0001104659-18-072097-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919006667/0001104659-19-006667-index.htm
2019-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/744218/000110465919027504/0001104659-19-027504-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919027513/0001104659-19-027513-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919036671/0001104659-19-036671-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919036997/0001104659-19-036997-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919037010/0001104659-19-037010-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919037195/0001104659-19-037195-index.htm
2019-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000110465919039565/0001104659-19-039565-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919044531/0001104659-19-044531-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919062181/0001104659-19-062181-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000110465920039253/0001104659-20-039253-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920057436/0001104659-20-057436-index.htm
2020-06-12S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000110465920072503/0001104659-20-072503-index.htm
2020-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/744218/000110465920072779/0001104659-20-072779-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920072934/0001104659-20-072934-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073386/0001104659-20-073386-index.htm
2020-06-15S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/744218/000110465920073505/0001104659-20-073505-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073843/0001104659-20-073843-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920074646/0001104659-20-074646-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465920077437/0001104659-20-077437-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920091459/0001104659-20-091459-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920096505/0001104659-20-096505-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920121786/0001104659-20-121786-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/744218/000110465920122483/0001104659-20-122483-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920122521/0001104659-20-122521-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318001754/0001171843-18-001754-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318002723/0001171843-18-002723-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318003787/0001171843-18-003787-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318005867/0001171843-18-005867-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318007706/0001171843-18-007706-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319001578/0001171843-19-001578-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319003062/0001171843-19-003062-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319005251/0001171843-19-005251-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319007429/0001171843-19-007429-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320002037/0001171843-20-002037-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320003372/0001171843-20-003372-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320005651/0001171843-20-005651-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320007664/0001171843-20-007664-index.htm
2018-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018003192/0001179110-18-003192-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018005108/0001179110-18-005108-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018006035/0001179110-18-006035-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018007858/0001179110-18-007858-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008556/0001179110-18-008556-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008557/0001179110-18-008557-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008558/0001179110-18-008558-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008559/0001179110-18-008559-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008560/0001179110-18-008560-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008561/0001179110-18-008561-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008562/0001179110-18-008562-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008563/0001179110-18-008563-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008564/0001179110-18-008564-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008565/0001179110-18-008565-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008566/0001179110-18-008566-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008567/0001179110-18-008567-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008568/0001179110-18-008568-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008569/0001179110-18-008569-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008570/0001179110-18-008570-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018009240/0001179110-18-009240-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010087/0001179110-18-010087-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018011797/0001179110-18-011797-index.htm
2018-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018012450/0001179110-18-012450-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018013378/0001179110-18-013378-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007967/0001179110-19-007967-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007968/0001179110-19-007968-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007969/0001179110-19-007969-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007970/0001179110-19-007970-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007971/0001179110-19-007971-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007972/0001179110-19-007972-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007973/0001179110-19-007973-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007974/0001179110-19-007974-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007975/0001179110-19-007975-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007976/0001179110-19-007976-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007977/0001179110-19-007977-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007978/0001179110-19-007978-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007979/0001179110-19-007979-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019008540/0001179110-19-008540-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007585/0001179110-20-007585-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007586/0001179110-20-007586-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007587/0001179110-20-007587-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007588/0001179110-20-007588-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007589/0001179110-20-007589-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007590/0001179110-20-007590-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007591/0001179110-20-007591-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007592/0001179110-20-007592-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007593/0001179110-20-007593-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007594/0001179110-20-007594-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007595/0001179110-20-007595-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007596/0001179110-20-007596-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007597/0001179110-20-007597-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007598/0001179110-20-007598-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000118248918000319/0001182489-18-000319-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312518041541/0001193125-18-041541-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312519039738/0001193125-19-039738-index.htm
2020-06-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312520171962/0001193125-20-171962-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000149315220011453/0001493152-20-011453-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/744218/999999999520001412/9999999995-20-001412-index.htm
2018-04-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/744218/999999999718005092/9999999997-18-005092-index.htm

Celldex Therapeutics, Inc (CLDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc (CLDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 16%
Institutional Ownership: 8207%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-09Margo Heath-ChiozziSVP of Regulatory AffairsBuy1,000.003.013,005.001,000.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-09Samuel Bates MartinSVP and CFOBuy9,750.003.0529,737.5010,735.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-09JAMES J MARINODirectorBuy8,305.003.0024,915.0012,704.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-10Sarah CavanaughSVP of Corp Affairs & Admin.Buy1,050.004.835,071.501,367.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-09Anthony S MarucciPresident & CEOBuy15,000.003.0645,900.0019,438.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-11Diane C. YoungSVP, Chief Medical OfficerBuy2,115.004.7310,003.952,115.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2018-06-15TIBOR KELERExecutive VP & CSOBuy16,500.000.599,782.8535,368.00https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-08-24JAMES J MARINODirectorBuy40,000.000.4819,200.0065,997.00https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2020-06-09TIBOR KELERExecutive VP & CSOBuy5,000.002.9914,954.007,357.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm